Overview

Gender

male

Investor Type

Investment Partner

Mr. Chen Qiyu is the executive Director and co-CEO of Fosun International. Mr. Chen joined the group in April 1994 and was appointed as a Director in May 2005. Mr. Chen is the chairman of Fosun High Tech, an executive director and a co-chief executive officer of Fosun International, a non-executive director and vice chairman of Sinopharm, a non-executive director of Babytree Group and a non-executive director and chairman of the board of directors of Shanghai Henlius, all of which are companies listed on the Hong Kong Stock Exchange.

My Chen Qiyu is also a director of Beijing Sanyuan Foods Co., Ltd., a company listed on the Shanghai Stock Exchange, and a co-chairman of the board of New Frontier Health Corporation, a company listed on the New York Stock Exchange.

Mr. Chen was a director of Maxigen Biotech Inc., a company listed on the Taiwan Stock Exchange and a director of Di’an Diagnostics Group Co., Ltd., a company listed on the growth enterprise board of the Shenzhen Stock Exchange. Mr. Chen is the chairman of China Medical Pharmaceutical Material Association, vice president of China Pharmaceutical Industry Research and Development Association, honorary chairman and chief supervisor of the Shanghai Biopharmaceutical Industry Association, vice chairman of the Shanghai Society of Genetics and a member of the 13th Shanghai Standing Committee of the Chinese People’s Political Consultative Conference.

Mr. Chen obtained a bachelor degree in genetics from Fudan University in July 1993 and an executive master of business administration from China Europe International Business School in September 2005.